Updated: 31-Oct-25 09:09 ET
Co: MPLT
MapLight Therapeutics (Nasdaq) | Clinical-stage biopharmaceutical company focused on improving the lives of patients suffering from debilitating central nervous system | Initial Shares: 14.8 M | Initial Range: $17.00-$17.00 | Priced On: 26-Oct-25, $17.00 | Opened: 27-Oct-25, $19.00 | Underwriters: Lead: Morgan Stanley, Jefferies, Leerink, Stifel
Co: NAVN
Navan (NasdaqGS) | Navan is an all-in-one platform for business travel, payments, and expenses, streamlining booking, spending, and reporting with 24/7 support and an intuitive user experience | Initial Shares: 36.9 M | Initial Range: $24.00-$26.00 | Priced On: 29-Oct-25, $25.00 | Opened: 30-Oct-25, $22.00 | Underwriters: Lead: Goldman Sachs & Co. LLC and Citigroup
There are no IPOs scheduled for this time period.
There are no IPOs scheduled for this time period.
There are no IPOs scheduled for this time period.
There are no IPOs scheduled for this time period.